Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Ebitda" stands at 12.50 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.95 percent compared to the value the year prior.
The 1 year change in percent is -28.95.
The 3 year change in percent is -45.69.
The 5 year change in percent is -41.60.
The 10 year change in percent is -53.86.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebitda | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebitda | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Ebitda | 280,205,508,085.11 |
![]() | Novartis AG - Ebitda | 255,096,620,580.91 |